HTG Molecular Diagnostics, Inc. provided revenue guidance for the full year 2021. For the year, the company expected to be approximately $8.9 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0015 USD | 0.00% |
|
0.00% | +15.38% |
2023 | Motion for De Minimus Asset Sale Approved for HTG Molecular Diagnostics, Inc. | CI |
2023 | Motion for De Minimus Asset Sale Filed by HTG Molecular Diagnostics, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
+15.38% | 3.32K | |
-29.89% | 15.53B | |
-59.28% | 2.01B | |
+13.05% | 1.78B | |
-19.84% | 1.33B | |
+26.03% | 1.27B | |
+2.36% | 810M | |
-37.93% | 713M | |
-38.97% | 696M | |
+22.41% | 589M |
- Stock Market
- Equities
- HTGMQ Stock
- News HTG Molecular Diagnostics, Inc.
- HTG Molecular Diagnostics, Inc. Provides Revenue Guidance for the Full Year 2021